Pure Biologics Spólka Akcyjna Cash Flow Reinvestment Rate
Pure Biologics Spólka Akcyjna cash flow reinvestment rate. Pure Biologics Spólka Akcyjna (PUR) has a Cash Flow Reinvestment Rate of 0.05x as of March 2024, reinvesting zł96.00K (capex zł85.00K plus investments zł-11.00K) from operating cash flow of zł2.04 Million. Explore cash flow to debt ratio of Pure Biologics Spólka Akcyjna to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pure Biologics Spólka Akcyjna (2019–2019)
Cash flow reinvestment rate of Pure Biologics Spólka Akcyjna from 2019 to 2019. Historical reinvestment intensity for Pure Biologics Spólka Akcyjna across 1 annual periods. Explore Pure Biologics Spólka Akcyjna capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Pure Biologics Spólka Akcyjna Cash Flow Reinvestment Rate by Year (2019–2019)
Pure Biologics Spólka Akcyjna cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Pure Biologics Spólka Akcyjna. For the full cash flow conversion analysis, see cash efficiency ratio of Pure Biologics Spólka Akcyjna.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 5.24x | zł27.97 Million | zł5.33 Million | zł161.92K | — |